Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FBP1 | P09467 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4464831 | 0.65 | — | — | |
| SCHEMBL29913029 | 0.63 | CDK2 (0.36) | — | |
| SCHEMBL29193359 | 0.63 | CDK2 (0.36) | — | |
| SCHEMBL19900526 | 0.62 | — | — | |
| SCHEMBL9905290 | 0.61 | KDM4E (0.59) | — | |
| SCHEMBL3263883 | 0.60 | PPARA (0.32) | — | |
| SCHEMBL4559345 | 0.58 | KMT2A (0.42) | — | |
| SCHEMBL572719 | 0.58 | PDPK1 (0.45) | — | |
| SCHEMBL1680218 | 0.56 | CYP2A6 (0.55) | — | |
| SCHEMBL3140312 | 0.55 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 38 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1140941-B1 | NITROGEN CONTAINING HETEROBICYCLES AS FACTOR XA INHIBITORS | BRISTOL MYERS SQUIBB PHARMA CO (US) | 2004-10-20 | — | — | EP | claimed |
| CN-114989630-B | Negative dichroic dye, preparation method thereof and display device | 江苏创拓新材料有限公司 | 2024-05-28 | — | — | CN | disclosed |
| CN-114621270-B | Condensed ring aromatic compound and application thereof in electroluminescent device | 清华大学 | 2024-04-12 | — | — | CN | disclosed |
| CN-115850992-B | Novel blue dichroic dye and application thereof | 江苏创拓新材料有限公司 | 2023-09-15 | — | — | CN | disclosed |
| CN-116615038-A | Organic electroluminescent device and display device | 清华大学 | 2023-08-18 | — | — | CN | disclosed |
| EP-3990592-A1 | USE OF A TRIAZOLE COMPOUND AS AN ADDITIVE FOR IMPROVING THE ANTI-CORROSION PROPERTIES OF A LUBRICANT COMPOSITION FOR A PROPULSION SYSTEM OF AN ELECTRIC OR HYBRID VEHICLE | Total Marketing Services (FR) | 2022-05-04 | — | — | EP | disclosed |
| WO-2020260457-A1 | USE OF A TRIAZOLE COMPOUND AS AN ADDITIVE FOR IMPROVING THE ANTI-CORROSION PROPERTIES OF A LUBRICANT COMPOSITION FOR A PROPULSION SYSTEM OF AN ELECTRIC OR HYBRID VEHICLE | TOTAL MARKETING SERVICES (FR) | 2020-12-30 | — | — | WO | disclosed |
| EP-2791294-A1 | LUBRICATING COMPOSITIONS FOR TRANSMISSIONS | Total Raffinage Marketing (FR) | 2014-10-22 | — | — | EP | disclosed |
| WO-2013087889-A1 | LUBRICATING COMPOSITIONS FOR TRANSMISSIONS | TOTAL RAFFINAGE MARKETING (FR) | 2013-06-20 | — | — | WO | disclosed |
| EP-1836169-B9 | COMPOSITIONS AND METHODS OF TREATING CELL PROLIFERATION DISORDERS | KINEX PHARMACEUTICALS LLC (US) | 2012-07-04 | — | — | EP | disclosed |
| EP-1264826-B1 | NOVEL IMIDAZOLINE COMPOUNDS | BANYU PHARMA CO LTD (JP) | 2005-03-30 | — | — | EP | disclosed |
| US-20040266854-A1 | Inhibitors of cyclin-dependent kinases, compositions and uses related thereto | GPC BIOTECH, INC. (US) | 2004-12-30 | — | — | US | disclosed |
| US-20040266853-A1 | Inhibitors of cyclin-dependent kinases, compositions and uses related thereto | GPC BIOTECH, INC. (US) | 2004-12-30 | — | — | US | disclosed |
| WO-2004092139-A2 | INHIBITORS OF CYCLIN-DEPENDENT KINASES, COMPOSITIONS AND USES RELATED THERETO | GPC BIOTECH, INC. (US) | 2004-10-28 | — | — | WO | disclosed |
| US-6800760-B2 | INHIBITORS OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR TYROSINE KINASE | CHIRON CORPORATION | 2004-10-05 | — | — | US | disclosed |
| EP-1446405-A2 | INHIBITORS OF CYCLIN-DEPENDENT KINASES, COMPOSITIONS AND USES RELATED THERETO | GPC Biotech Inc. (US) | 2004-08-18 | — | — | EP | disclosed |
| US-20030158418-A1 | Novel imidazonline compounds | MSD K.K. (JP) | 2003-08-21 | — | — | US | disclosed |
| WO-2003033499-A2 | INHIBITORS OF CYCLIN-DEPENDENT KINASES, COMPOSITIONS AND USES RELATED THERETO | GPC BIOTECH INC. (US) | 2003-04-24 | — | — | WO | disclosed |
| EP-1264826-A1 | NOVEL IMIDAZOLINE COMPOUNDS | BANYU PHARMACEUTICAL CO., LTD. (JP) | 2002-12-11 | — | — | EP | disclosed |
| US-4963544-A | THIENAMYCIN ANTIBIOTICS | FUJISAWA PHARMACEUTICAL COMPANY, LTD. (JP) | 1990-10-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040266853-A1 | Inhibitors of cyclin-dependent kinases, compositions and uses related thereto | CDK1, CCNO, CCNI | FBP1 1178/4885 |
| US-20040266854-A1 | Inhibitors of cyclin-dependent kinases, compositions and uses related thereto | CDK1, CCNO, CCNI | FBP1 1178/4885 |
| US-20030158418-A1 | Novel imidazonline compounds | NPY1R, NPY2R, GPR119 | FBP1 2425/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.